Anthem Biosciences IPO Allotment Status Today – How to Check via KFin, BSE, NSE

Anthem Biosciences IPO Allotment Status Live: What Investors Need to Know Today

The buzz around the Anthem Biosciences IPO allotment status has reached a fever pitch as investors eagerly await confirmation of their share allocations. With the IPO closing on July 16, 2025, and the allotment process expected to be finalized today, July 17, thousands of retail and institutional investors are checking their status via KFin Technologies, BSE, and NSE platforms.

Anthem Biosciences Ltd launched its ₹3,395 crore IPO as a mainboard Offer for Sale (OFS), with a price band set between ₹540 and ₹570 per share. The minimum lot size for bidding was 26 shares. The IPO opened for subscription on July 14 and closed on July 16, 2025. The allotment finalization is scheduled for July 17, and the listing is expected to take place on July 21, 2025, on both BSE and NSE. KFin Technologies is the official registrar for the IPO.

Subscription Details and Market Response

The IPO witnessed overwhelming demand across all investor categories. Qualified Institutional Buyers (QIBs) subscribed 192.80 times, Non-Institutional Investors (NIIs) subscribed 44.70 times, Retail Individual Investors (RIIs) subscribed 5.98 times, and the employee quota saw a subscription of 6.99 times. This strong response reflects high investor confidence in Anthem Biosciences’ growth potential and market positioning.

How to Check Anthem Biosciences IPO Allotment Status Online

Investors can check their IPO allotment status through three primary platforms: KFin Technologies, BSE, and NSE.

To check via KFin Technologies, visit their IPO status page, select “Anthem Biosciences Ltd” from the dropdown, and enter your PAN, Application Number, or DP Client ID. Complete the captcha and click “Search” to view your allotment status.

On the BSE website, choose “Equity” as the issue type, select “Anthem Biosciences Ltd,” and enter your Application Number and PAN. After completing the captcha, click “Search.”

For NSE, navigate to the IPO bid details section, select “Anthem Biosciences,” and enter your PAN and Application Number. Click “Submit” to check your status.

Grey Market Premium (GMP) & Listing Expectations

As of July 17, 2025, the Grey Market Premium (GMP) for Anthem Biosciences IPO is trending between ₹144 and ₹151. This suggests a potential listing price in the range of ₹714 to ₹721 per share, which is approximately 25 to 26 percent above the upper price band of ₹570. The rising GMP indicates strong investor sentiment and expectations of a robust listing performance.

Why This Is Trending Right Now

The Anthem Biosciences IPO is trending today for several reasons. First and foremost, July 17 marks the allotment finalization date, making it a crucial day for investors who participated in the offering. The IPO was heavily oversubscribed, with a total subscription of 67.42 times, driven primarily by institutional demand. The GMP has also surged in recent days, reflecting bullish market sentiment and anticipation of a premium listing.

Additionally, the upcoming listing on July 21 has created a buzz among market participants. Investors are actively tracking allotment updates and preparing for potential listing gains. The IPO’s strong fundamentals, coupled with its high demand, have made it one of the most talked-about offerings in recent weeks.

Frequently Asked Questions (FAQ)

Q1: When will Anthem Biosciences shares be credited to my demat account?

Shares will be credited by July 18, 2025.

Q2: What if I didn’t get an allotment?

Refunds for unallotted shares will be initiated on July 18.

Q3: Is the GMP a reliable indicator of listing price?

GMP offers a speculative view but is not guaranteed. Market conditions on listing day may vary.

Q4: Can I check allotment status using my PAN?

Yes, you can use your PAN, Application Number, or DP Client ID on KFin, BSE, or NSE platforms.

Q5: What does an oversubscription of 67x mean?

It means demand for shares was 67 times higher than the available supply, indicating strong investor interest.

Final Thoughts

The Anthem Biosciences IPO allotment status is the focal point of investor attention today. With allotments being finalized and GMP showing strong upward momentum, the IPO is poised for a promising debut on July 21. The oversubscription across all categories underscores the market’s confidence in the company’s future.